59P Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Nonsquamous (NSQ) histology in the phase III TROPION-Lung01 trialN. Girard, M-J. Ahn, Aaron Lisberg et al.|ESMO Open|2024Cited by 5